Literature DB >> 1279215

Idiopathic resistance to luteinizing hormone-releasing hormone analogue in a patient with prostatic carcinoma.

J L Jorion1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279215     DOI: 10.1016/s0022-5347(17)36962-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  1 in total

1.  Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer.

Authors:  Yoko Koh; Atsunari Kawashima; Takeshi Ujike; Akira Nagahara; Kazutoshi Fujita; Hiroshi Kiuchi; Ryoichi Imamura; Yasushi Miyagawa; Norio Nonomura; Motohide Uemura
Journal:  Anticancer Drugs       Date:  2020-11       Impact factor: 2.389

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.